GSE110626
RNA sequencing data from triple-negative breast cancer patient-derived xenografts (PDX)
RNAseq was performed on WHIM2 and WHIM30 PDX mammary tumors, brain metastases, and single cell suspensions over time. Overall design: Comparison of gene expression profiles between two PDX models of triple-negative breast cancer, and between primary tumors, cell suspensions, and brain metastases within the PDX lines.